Cargando…

Modifying macronutrients is superior to microbiome transplantation in treating nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver injury and liver transplantation in Western countries. The pathogenesis of NAFLD includes overnutrition-associated metabolic syndrome or the improper consumption of dietary macro- and micro-nutrients that either support o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitsinikos, Fontini Tania, Chac, Denise, Schillingford, Nicholas, DePaolo, R. William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524401/ https://www.ncbi.nlm.nih.gov/pubmed/32816619 http://dx.doi.org/10.1080/19490976.2020.1792256

Ejemplares similares

Diet Macronutrients Composition in Nonalcoholic Fatty Liver Disease: A Review on the Related Documents
por: Hashemi Kani, Ali, et al.
Publicado: (2014)

Gut Microbiome and Intestinal Permeability Are Promising Targets for Treating Nonalcoholic Fatty Liver Disease
por: Heshmati, Hassan Massoud
Publicado: (2021)

The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease
por: Roychowdhury, Sanjoy, et al.
Publicado: (2018)

Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Abdollahiyan, Sara, et al.
Publicado: (2023)

Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
por: Castillo-Castro, Carolina, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease after Liver Transplant
por: Shetty, Akshay, et al.
Publicado: (2021)

Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis
por: Satapathy, Sanjaya K., et al.
Publicado: (2020)

Macronutrients and the Adipose-Liver Axis in Obesity and Fatty Liver
por: Duwaerts, Caroline C., et al.
Publicado: (2019)

Treating Nonalcoholic Fatty Liver Disease From the Outside In?
por: Flynn, Charles R.
Publicado: (2019)

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
por: Caussy, Cyrielle, et al.
Publicado: (2019)

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
por: Koning, Mijra, et al.
Publicado: (2023)

Components of human breast milk: from macronutrient to microbiome and microRNA
por: Kim, Su Yeong, et al.
Publicado: (2020)

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
por: Qadri, Sami, et al.
Publicado: (2021)

What are the key points in the association between the gut microbiome and nonalcoholic fatty liver disease?
por: Vallianou, Natalia, et al.
Publicado: (2019)

The Wealth of Nations and the First Wave of COVID-19 Diffusion
por: Antonietti, Roberto, et al.
Publicado: (2021)

Influence of aging, macronutrient composition and time-restricted feeding on the rat gut microbiome
por: Hernandez, Abbi, et al.
Publicado: (2020)

Body Metrics and the Gut Microbiome in Response to Macronutrient Limitation in the Zebrafish Danio rerio
por: Green, George B.H., et al.
Publicado: (2023)

The transcontinental variability of nonalcoholic fatty liver disease
por: Oliveira, Claudia P., et al.
Publicado: (2020)

Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease
por: Yang, Fuyuan, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2018)

Bone-Anchored Hearing Aid vs. Reconstruction of the External Auditory Canal in Children and Adolescents with Congenital Aural Atresia: A Comparison Study of Outcomes
por: Farnoosh, Soroush, et al.
Publicado: (2014)

Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health
por: Oliphant, Kaitlyn, et al.
Publicado: (2019)

Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health
por: Jardon, Kelly M, et al.
Publicado: (2022)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson’s Disease
por: Bajracharya, Rijan, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar, Raiya, et al.
Publicado: (2018)

Role of Dietary Macronutrients and Fatty Acids in Obesity and Metabolic Risk in Older Adults
por: Dooley, Cara, et al.
Publicado: (2019)

Erratum to “Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease”
por: Yang, Fuyuan, et al.
Publicado: (2022)

Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic intervention
por: Mouzaki, Marialena, et al.
Publicado: (2019)

Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease
por: Behari, Jaideep, et al.
Publicado: (2021)

The role of microbiome in the pathogenesis of oral-gut-liver axis between periodontitis and nonalcoholic fatty liver disease
por: Chen, Tsung-Po, et al.
Publicado: (2023)

Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
por: Mowry, Christopher J., et al.
Publicado: (2021)

Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease
por: Chen, Yifei, et al.
Publicado: (2022)

Ferroptosis resistance cooperates with cellular senescence in the overt stage of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
por: Vetuschi, Antonella, et al.
Publicado: (2022)

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
por: Younossi, Zobair M., et al.
Publicado: (2017)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Macronutrient balance and lifespan
por: Simpson, Stephen J., et al.
Publicado: (2009)

Lactobacillus lactis CKDB001 ameliorate progression of nonalcoholic fatty liver disease through of gut microbiome: addendum
por: Lee, Na Young, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8rr28l59r99gdmqa26su61d77e